The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 study of pembrolizumab in advanced small-cell lung cancer (SCLC): KEYNOTE-158.
 
Hyun Cheol Chung
Consulting or Advisory Role - Bristol-Myers Squibb; Celltrion; Lilly; Merck Serono; MSD; Quintiles; Taiho Pharmaceutical
Speakers' Bureau - Foundation medicine; Lilly; Merck Serono
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck Serono; MSD; Taiho Pharmaceutical
 
Jose A. Lopez-Martin
Stock and Other Ownership Interests - PharmaMar
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Caris Life Sciences; Celgene; GlaxoSmithKline; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Roche Molecular Diagnostics (Inst)
Patents, Royalties, Other Intellectual Property - PharmaMar
Travel, Accommodations, Expenses - MSD Oncology; Roche
 
Stephen Chuan-Hao Kao
Honoraria - AstraZeneca; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Roche
 
Wilson H. Miller
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche
Research Funding - Amgen; AstraZeneca; Bristol-Myers Squibb; MedImmune; Merck; MethylGene; Novartis; Pfizer; Roche
 
Willeke Ros
No Relationships to Disclose
 
Bo Gao
Consulting or Advisory Role - MSD
 
Aurelien Marabelle
Honoraria - AMGEN; AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Merck Serono; Roche/Genentech; Sanofi; SERVIER
Consulting or Advisory Role - AMGEN; Eisai; etherna; GENMAB; GENTICEL; GlaxoSmithKline; Kyowa Hakko Kirin; Lytix Biopharma; Merck Serono; NEKTAR; NOVARTIS; Pfizer; Pierre Fabre; RIGONTEC; Symphony Evolution
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MERUS (Inst); Transgene (Inst)
Patents, Royalties, Other Intellectual Property - monoclonal antibodies against CD81 (Stanford University)
Other Relationship - PEGASCY
 
Maya Gottfried
No Relationships to Disclose
 
Alona Zer
Consulting or Advisory Role - Lilly; Novartis
Research Funding - Bristol-Myers Squibb (Inst)
Other Relationship - AstraZeneca; Lilly; MSD; Roche
 
Jean-Pierre Delord
No Relationships to Disclose
 
Nicolas Penel
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag
 
Shadia Ibrahim Jalal
Research Funding - AstraZeneca/MedImmune
 
Lei Xu
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Susan Zeigenfuss
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Scott K. Pruitt
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Sarina Anne Piha-Paul
Consulting or Advisory Role - Genentech
Research Funding - Abbvie; Bayer; BlueLink; Curis; Five Prime Therapeutics; GlaxoSmithKline; Helix BioPharma; Incyte; MedImmune; Medivation; Merck Sharp & Dohme; Novartis; Pfizer; Pieris Pharmaceuticals; Principa Biopharma; Puma Biotechnology; Tesaro; XuanZhu